Sharda Corp- follow-up
CMP :2925. long way to go.
Sharda Corp- follow-up
CMP :2925. long way to go.
Care Ratings is only for the patient investor, its has a long runway for the simple reason that Credit Cycle is not currently playing out, and when its starts, CARE being one of the 3 beneficiaries in the rating space will be at an advantage. The company also has some subsidiaries, which have potential to throw up some surprises. one such subsidiary is “Care Edge Analytics” it has great scope for growth.
Just check for Moody’s Analytics has grown, and it is a global leader in its space.
https://www.moodys.com/web/en/us/insights/announcements/moodysanalytics-is-now-moodys.html
check out their products.
Every drop in the stock is a great chance to add.
Let’s see if it works, otherwise we all can continue small & microcap discussions here.
We should strictly adhere to the guidelines and have to ensure that no buy sell recommendations are made or suggested.
I got a message saying that the bonus shares have been credited, but when I check my demat a/c, I don’t see the credit. Very strange. And no, there wouldn’t be anything required to be done by us.
I have a few queries - does anyone have any ideas on the same?
Hello,
In the below tracker, I have started tracking important company goals for Ganesha Ecosphere.These goals are referred to as ‘monitorables’ in the tracker.I will update this document regularly to reflect the current status of these goals.
Here’s a snapshot of what the tracker includes:
I hope this information makes it easier to observe how well companies are progressing towards their stated goals.
Screenshot of the tracker below:
Full tracker attached below:
Tracking Company Monitorables-17.xlsx (130.6 KB)
No action taken on the portfolio so again nothing much to report except that I just saw today that returns breached 50% for the portfolio. And I had started this portfolio in Jan this year thinking I am getting into Momentum at a wrong time. Markets continue to surprise.
Portfolio start date → Jan 23, 2024
Total returns → 50.5%
also , not as primary thesis , madhu kela is also in the list of investors , it is less covered institutionally, driving the data center theme , as more quality capital flows into this sector they will look at strong established partners in this sector to provide them with electronic equipment’s and rptech stands strong in this segment , i do agree with Ashar also about the trading company, but if someone in this industry has to leap from a trading company to a larger corporation with value add , they are well positioned to grab this opportunity, and NVIDIAS computer share increasing in B2B utilities will directly benifit them in sectors like pharma ( just gave u a small summary of my thesis ) , management seems very confident
disclaimer - invested from 335 , 5% position
Hi Amit, hope you are holding the company, the company has received two orders recently worth 900 Crores and I think they will complete this order in the next 3-5 years with 16-17% EBITDA which will give them 140-150 Crores of EBITDA and PAT of almost 100 crores. Have you met the promoters? if yes whats their take?
Do you think promoters have a hunger for growth?
Do you think they will execute it well?
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!